Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$151,593,980
+$118,002,788 QoQ
Shares Held
1,558,807
+269.6% QoQ
Ownership
0.733%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 98.84815759744471.ToString("F0")%
Shared 0.ToString("F0")%
None 1.1518424025552876.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,509,413,147 across 314 Biotechnology names. RVMD ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
This page
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in RVMD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $151,593,980 | 1,558,807 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,591,192 | 421,735 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $425,296 | 9,107 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $1,038,288 | 22,895 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $883,199 | 22,757 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $810,810 | 25,157 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,579,966 | 89,957 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,057,011 | 74,314 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,987,525 | 74,300 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,247,441 | 103,760 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $647,904 | 27,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,730,312 | 138,454 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,062,282 | 54,504 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,593,874 | 140,881 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,207,790 | 127,445 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,120,569 | 113,434 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,866,122 | 121,806 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $942,008 | 20,532 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||